Kevin Kotler, Broadfin Capital Add Some More Cardica, Inc. (CRDC) Shares To Their Portfolio

Kevin Kotler and his fund, Broadfin Capital, have further boosted their holding of Cardica, Inc. (NASDAQ:CRDC) stock. According to a recent filing with the Securities and Exchange Commission, Kotler and Broadfin have added 500,000 shares of Cardica, Inc. (NASDAQ:CRDC) to their portfolio, taking their investment in the company to 8.87 million shares, which account for 9.98% of the total number of shares outstanding. At the end of May, Broadfin’s stake had registered a massive boost from approximately 640,000 to more than 8 million shares.

Kevin Kotler
Chuck Royce is also bullish on Cardica, Inc. (NASDAQ:CRDC) and has initiated a position for his fund during the first quarter. As a result, Royce & Associates has reported ownership of 169,600 shares at the end of March. Phil Frohlich doesn’t seem to be so optimistic and has chosen to trim his fund’s stake in the company. Prescott Group Capital Management reportedly holds 1.96 million shares, down 2% during the quarter. Nathan Fischel, the manager of Dafna Capital Management, has followed suit and has cut his fund’s stake by 1% to 1.05 million shares.
Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!